Children's National Medical Center Inc.

11/18/2026 | Press release | Distributed by Public on 11/18/2026 20:21

Children’s National leads in human neonatal and infant airway biology with K24 award - Children's National

Dr. Nino next to image of a human baby epithelial cell culture with experimental in vitro RSV infection.

Gustavo Nino, MD, chief of Pulmonology and Sleep Medicine, part of the Heart and Lung Center at Children's National, recently received the National Institutes of Health (NIH) Midcareer Investigator Award in Patient-Oriented Research, also known as a K24 award.

The award provides established clinician-scientists with protected time to advance patient-oriented research and mentor junior investigators. Recipients must demonstrate a strong record of NIH-funded research and mentorship while proposing an area of science where additional expertise and investigators are needed. For Dr. Nino, that focus is on human neonatal and infant airway biology.

Over the five-year grant, Dr. Nino and his team will build on more than a decade of work at Children's National to better understand how the human airway develops and responds to respiratory infections early in life. The long-term goal is to identify new ways to prevent and treat respiratory disease.

Ultimately, the program is expected to be the only one of its kind in the nation, positioning Children's National as a hub for knowledge, research and training in early airway biology and immunity.

The big picture

At the center of the K24 award is a proposal to establish a patient-oriented research mentoring program in human neonatal and infant airway biology at Children's National. The program will build upon research resources developed by Dr. Nino and his team to study airway epithelial cells, which line the respiratory tract and serve as an important first line of defense against viruses.

While this initial work has already supported the training of more than 40 mentees, the K24 project will provide a more formal platform for investigators interested in the field, combining mentorship and training with opportunities to conduct cellular, molecular and clinical research involving newborns and infants.

Children's National is well positioned to lead this work because its researchers have access to pediatric patient populations and specialized research tools needed to study airway biology directly in children. That allows investigators to develop human-based models of both healthy and diseased airways and examine biological processes that can be difficult to replicate through other research models.

The research could ultimately help scientists better understand why severe viral respiratory infections early in life can have consequences that extend well beyond infancy, including an increased risk of asthma and chronic obstructive pulmonary disease later in life.

The hold up in the field

Despite the significant burden respiratory infections place on infants, much remains unknown about how the airway's immune defenses develop and function during the earliest stages of life.

The K24 research will focus in part on infants born severely premature and infants with trisomy 21, or Down syndrome. Both groups have historically been underrepresented in respiratory research despite facing a higher risk of severe respiratory infections.

Previous research from Dr. Nino and his team suggests that cells lining the newborn airway can mount strong antiviral responses that help compensate for the immature adaptive immune system early in life. Through the K24 grant, researchers will investigate how these responses develop and how premature birth and trisomy 21 may alter them. They will also examine whether those differences help explain why certain infants experience more severe respiratory infections.

Children's National leads the way

The K24 recognizes Dr. Nino's research and mentoring record as well as the infrastructure Children's National has built to advance the field. With the award, Children's National is establishing a dedicated human neonatal and infant airway biology research and mentoring initiative designed to bring research, clinical expertise, relevant patient populations and training together in one place.

For trainees, that means entering an established program rather than having to build a research and training pathway independently. Investigators will have access to mentorship, patient-oriented research resources and opportunities to study airway biology in populations that have historically been difficult to include in research.

The goal is an epicenter for research and training in human infant airway biology, one that generates new knowledge about how respiratory disease begins and prepares more investigators to carry the field forward.

Children's National Medical Center Inc. published this content on November 18, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 19, 2026 at 02:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]